Keywords: ACC/AHA Clinical Practice Guidelines; Acute coronary syndrome; Anticoagulants; Anticoagulation agents; Antiplatelet agents; Apixaban; Atrial fibrillation; Atrial flutter; Cardioversion; Coronary artery disease; Coronary heart disease; Dabigatran; Edoxaban; Focused update; Hypertension; Idarucizumab; Myocardial infarction; Obesity; Percutaneous coronary intervention; Risk factors; Rivaroxaban; Sleep apnea; Stents; Stroke; Thromboembolism; Warfarin.